Johnson Matthey (JMPLY)
(Delayed Data from OTC)
$44.52 USD
+0.59 (1.34%)
Updated Jul 12, 2024 01:09 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Price, Consensus and EPS Surprise
JMPLY 44.52 +0.59(1.34%)
Will JMPLY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for JMPLY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for JMPLY
Johnson Matthey (JMPLY) Sells Medical Device Unit for $700M
Is Hawkins (HWKN) Stock Outpacing Its Basic Materials Peers This Year?
JMPLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Johnson Matthey (JMPLY) Stock Undervalued Right Now?
JMPLY vs. AIQUY: Which Stock Is the Better Value Option?
Should Value Investors Buy Johnson Matthey (JMPLY) Stock?
Other News for JMPLY
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
IN BRIEF: Johnson Matthey launches tranche of GBP250 million buyback
Deutsche Numis Sticks to Its Buy Rating for Johnson Matthey (JMAT)
Gelion shares soar 57% following announcement of Glencore partnership